Dr. Bolin Chen 陈柏林
Chief Physician, Associate Professor
Department of Medical Oncology, Hunan Cancer Hospital, Changsha
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Chemotherapy, targeted therapy, and immunotherapy for lung cancer and other thoracic tumors. Biopsy procedures including EBUS-TBNA, CT-guided percutaneous lung puncture, and EUS-FNA for complex cases.
Dr. Chen is a Chief Physician at Hunan Cancer Hospital with a PhD in Internal Medicine from Central South University Xiangya School of Medicine. Dr. Chen pioneered EBUS-TBNA at the hospital, receiving a 2015 New Technology Award. Dr. Chen has participated in nearly 100 multi-center clinical studies and serves as Principal Investigator for several domestic trials.
Professional roles
- Member, Lung Nodule Molecular Biomarker Collaboration Group, Tumor Marker Professional Committee, China Anti-Cancer Association
- Expert Committee Member, Medication Service Platform, China Anti-Cancer Association
- Member, Tumor Clinical Research Innovation and Development Professional Committee, China Medicine Education Association
- Member, Lung Cancer Professional Committee, China Health Care Association
Name order: in Chinese the family name comes first (Chen Bolin). Papers usually list the name as Bolin Chen or Chen B.
Selected publications
45 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Transl Med, 2026 (senior author): Gamabufotalin suppresses pancreatic cancer through redox-homeostasis disruption by G6PD downregulation. PubMed 42310762
- J Immunother, 2026 (senior author): Sugemalimab for Post-PD-1 Progression in Non-small Cell Lung Cancer. PubMed 41804869
- Biochem Pharmacol, 2026 (senior author): Gamabufotalin impedes NSCLC progression by inhibiting the mitochondrial factor CHCHD2 and modulating XAF1 expression. PubMed 41692347
- Life Sci, 2025 (senior author): The crosstalk between lung adenocarcinoma cells and M2 macrophages promotes cancer cell development via the SFRS1/miR-708-5p/PD-L1 axis. PubMed 40185466
- Clin Transl Med, 2025 (senior author): Neutrophil extracellular traps promote growth of lung adenocarcinoma by mediating the stability of m6A-mediated SLC2A3 mRNA-induced ferroptosis resistance and CD8(+) T cell inhibition. PubMed 39865544
- J Mater Chem B, 2024 (senior author): Illuminating cisplatin-induced ferroptosis in non-small-cell lung cancer with biothiol-activatable fluorescent/photoacoustic bimodal probes. PubMed 39530521
- Phytomedicine, 2024 (senior author): A multi-omic analysis reveals that Gamabufotalin exerts anti-hepatocellular carcinoma effects by regulating amino acid metabolism through targeting STAMBPL1. PubMed 39348778
- J Thorac Dis, 2024 (senior author): Efficacy and safety of sintilimab in combination with chemotherapy for recurrent extensive-stage small cell lung cancer: a real-world retrospective study. PubMed 38983156
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion